MedTrace Logo

Beta-Blockers in Heart Failure: Pharmacy-level Intervention Comparison

NCT01002456 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 220

Last updated 2015-04-28

Study results available
· View outcomes & findings →

Summary

The overall objective of the proposed pilot study is to begin evaluation of two methods for promoting adherence to guidelines for beta-blocker therapy in heart failure. The design includes site level baseline measurement, feedback, remeasurement after six months, and randomized (by site) comparison samples. The setting is VA sites, with intervention directed at the pharmacy.

Conditions

Interventions

OTHER

Level 1: (provide site-specifi information)

provide site-specific information on non-adherence to guideline

OTHER

Level 2 (Provide site- and patient-specific information)

provide site-specific information on non-adherence to guideline as well as list of patients with non-adherent prescriptions

Sponsors & Collaborators

Principal Investigators

  • Madeline McCarren, PhD MPH · Edward Hines Jr. VA Hospital, Hines, IL

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2011-06-30
Completion
2012-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01002456 on ClinicalTrials.gov